Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Cancer Research|July 3, 2021
Quantitative <i>In Vivo</i> Analyses Reveal a Complex Pharmacogenomic Landscape in Lung AdenocarcinomaChuan Li, Wen-Yang Lin, Hira Rizvi, et al.Journal for Immunotherapy of Cancer|February 11, 2021
Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockadeJason Beattie, Hira Rizvi, Paige Fuentes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2021
Response to Standard Therapies and Comprehensive Genomic Analysis for Patients with Lung Adenocarcinoma with <i>EGFR</i> Exon 20 InsertionsNoura J Choudhury, Adam J Schoenfeld, Jessica Flynn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2021
Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung CancerKathryn C Arbour, Hira Rizvi, Andrew J Plodkowski, et al.Journal for Immunotherapy of Cancer|August 6, 2020
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance statusJoao V Alessi, Biagio Ricciuti, Elizabeth Jiménez-Aguilar, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2021
Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse EventsJia Luo, Jason A Beattie, Paige Fuentes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with <i>EGFR</i>-Mutant Lung CancersMichael Offin, Hira Rizvi, Megan Tenet, et al.Cancer Immunology Research|July 12, 2018
Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLCFernando C Santini, Hira Rizvi, Andrew J Plodkowski, et al.JCO Clinical Cancer Informatics|February 22, 2022
A Scalable Quality Assurance Process for Curating Oncology Electronic Health Records: The Project GENIE Biopharma Collaborative ApproachJessica A Lavery, Eva M Lepisto, Samantha Brown, et al.Cancer Discovery|September 22, 2020
Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 BlockadeKathryn C Arbour, Anh Tuan Luu, Jia Luo, et al.Pageof 6